HRT Financial’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History

HRT Financial’s Portfolio HLGN.WS Stock Details HLGN.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-19,563	Closed	-$5K	–	3719
2022 Q2	$5K	Sell	19,563 -5,437	-22%	-$3.22K	﹤0.01%	2746
2022 Q1	$30K	Hold	25,000	–	–	﹤0.01%	2787
2021 Q4	$42K	Buy	+25,000	New	+$42.5K	﹤0.01%	2865

Other funds holding HLGN.WS

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

HRT Financial's HLGN.WS Position: Q3 2022 in Review

HRT Financial sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q3 2022, closing a stake of 19,563 shares — an estimated $5K sold.

HRT Financial first reported a position in HLGN.WS in Q4 2021 and held it in 3 quarters. The position peaked at $42K in Q4 2021. 17 funds tracked by Wall St. Rank hold HLGN.WS as of Q3 2022.

HRT Financial reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q3 2022 after selling out during the quarter.
HRT Financial sold 19,563 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q3 2022, an estimated $5K.
HRT Financial first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2021 and held it in 3 quarters.
HRT Financial's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $42K in Q4 2021.
17 funds tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.